24
Participants
Start Date
January 31, 2016
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Lofexidine
All subjects will receive two single doses of lofexidine HCl; one 0.4 mg dose taken alone on Day 1 and one 0.4 mg dose taken with 40 mg once daily paroxetine HCl at steady-state on Day 13.
Paroxetine
All subjects will receive daily single doses of paroxetine HCl; one 20 mg dose taken Days 4-6, one 40 mg dose taken Days 7-19, one 20 mg dose taken Day 20, one 10 mg dose taken Days 21-22.
Worldwide Clinical Trials, San Antonio
National Institute on Drug Abuse (NIDA)
NIH
USWM, LLC (dba US WorldMeds)
INDUSTRY